is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Wednesday 8th May, 15:20 - 17:20
The medicinal use of Cannabis is now legal in Europe, but what about CBD? Even though CBD as a substance is not considered a narcotic, there is great confusion about what is allowed in Europe regarding food use. For botanicals, the situation of CBD is far from being harmonised.
In our CBD summit we will look at the future opportunities for CBD in the food space as well as the current legal circumstances within Europe regarding this highly promising substance.
Chair: Joerg Gruenwald, United States Pharmacopoeia (USP) Committee for Botanical Dietary Supplements and Herbal Medicines
15:20 - 15:50
It is high time for CBD supplements in the EU?
Speaker: Dr Heike Stier, Senior Consultant, analyze & realize GmbH, (Germany)
15:50 - 16:20
Food products derived from Cannabis sativa L: what’s the current state of play?
Speaker: Karin Verzijden, Life Sciences Lawyer, Axon Lawyers (The Netherlands)
16:20 - 17:20
The GenCanna Production Platform
Speaker: Garrett Bain, Chief Sales Officer, GenCanna Global USA (United States)
16:50 - 17:20
Secondary metabolites profiled in cannabis plant parts
Speaker: Dan Jin, Analyst at Labs-Mart and PhD student, Biomedical Engineering Department, University of Alberta (Canada)